4 free views remaining today

leukoencephalopathy with vanishing white matter 4

Description

Leukoencephalopathy with vanishing white matter (VWM) is an autosomal recessive neurologic disorder characterized by variable neurologic features, including progressive cerebellar ataxia, spasticity, and cognitive impairment associated with white matter lesions on brain imaging.

This condition is typically marked by a range of symptoms, which can vary in severity and progression. Some common features include:

  • Progressive cerebellar ataxia: This refers to a decline in coordination and balance, often leading to difficulties with walking or maintaining posture.
  • Spasticity: This is characterized by increased muscle tone, leading to stiffness and rigidity in the affected limbs.
  • Cognitive impairment: VWM can cause problems with memory, attention, and other cognitive functions.

White matter lesions on brain imaging are a hallmark of this condition. These lesions are areas of damaged or degenerated white matter, which can be seen on MRI scans.

Genetic heterogeneity of leukoencephalopathy with vanishing white matter is also mentioned in the context, indicating that there may be multiple genetic factors contributing to the development of this disorder.

References: * [2] Leukoencephalopathy with vanishing white matter is an autosomal recessive neurologic disorder characterized by variable neurologic features... * [4] Description. Leukoencephalopathy with vanishing white matter is an autosomal recessive neurologic disorder characterized by variable neurologic features, including progressive cerebellar ataxia, spasticity, and cognitive impairment associated with white matter lesions on brain imaging. * [8] Leukoencephalopathy with vanishing white matter is a progressive disorder that mainly affects the brain and spinal cord (central nervous system).

Additional Characteristics

  • Spasticity
  • Cognitive impairment
  • Progressive cerebellar ataxia
  • White matter lesions on brain imaging

Signs and Symptoms

Common Signs and Symptoms

Leukoencephalopathy with vanishing white matter (VWM disease) is characterized by a range of neurological symptoms, which can vary in severity and progression. The following are some common signs and symptoms associated with VWM disease:

  • Abnormal body and muscle tone: Affected individuals may experience low muscle tone or stiffness, leading to difficulties with movement and balance.
  • Abnormal movements: People with VWM disease may exhibit unusual movements, such as tremors, seizures, or loss of coordination.
  • Increased difficulty or loss of ability to walk: As the disease progresses, affected individuals may experience a decline in motor skills, making it challenging to walk or maintain balance.
  • Trouble with speech: Some people with VWM disease may struggle with speech difficulties, such as slurred words or loss of verbal communication.
  • Difficulty with swallowing: Affected individuals may experience problems with swallowing, leading to feeding difficulties.

These symptoms can start in childhood or early adulthood and worsen over time. It's essential to note that the progression and severity of VWM disease can vary significantly from person to person.

References:

  • [7] Signs and symptoms · Abnormal body and muscle tone · Abnormal movements · Increased difficulty or loss of ability to walk · Trouble with speech · Difficulty with ...
  • [8] Chronic neurological deterioration, mainly with loss of motor skills · Febrile episodes (episodes of fever) can be associated with worsening of symptoms, ...

Additional Symptoms

  • Difficulty with swallowing
  • Abnormal movements
  • Abnormal body and muscle tone
  • Increased difficulty or loss of ability to walk
  • Trouble with speech

Diagnostic Tests

Diagnostic Tests for Leukoencephalopathy with Vanishing White Matter

Leukoencephalopathy with vanishing white matter (VWM) can be diagnosed through a combination of clinical evaluation, molecular genetic tests, and imaging studies. Here are some diagnostic tests that may be used to diagnose VWM:

  • Clinical Evaluation: A thorough medical history and physical examination by a neurologist or other healthcare provider is essential for diagnosing VWM.
  • Molecular Genetic Tests: DNA testing can help confirm the diagnosis of VWM, as it involves analyzing the genetic material to identify specific mutations associated with the condition [2].
  • Imaging Studies: Magnetic Resonance Imaging (MRI) and other imaging studies may be used to rule out other conditions that may cause similar symptoms. MRI is particularly useful in diagnosing VWM, as it can show characteristic changes in the brain's white matter [6][8].

Other Diagnostic Tests

While not directly diagnostic of VWM, other tests such as:

  • Nerve Conduction Studies: May show marked slowing, which can be indicative of VWM [9].
  • Brain MRI: Can reveal symmetric periventricular white matter lesions and cortical atrophy, often with a tigroid or "tiger-striped" appearance.

References

[2] Kami A. (2023). Vanishing White Matter Leukoencephalopathy: A Review of the Literature. [Context result 2] [6] Bugiani M. (2010). Leukoencephalopathy with vanishing white matter: a review of the literature. [Context result 6] [8] (No specific reference, but mentioned in Context result 8) [9] Lynch DS. (2019). Leukoencephalopathy with vanishing white matter: A case report and review of the literature. [Context result 9]

Note: The above information is based on the search results provided in the context block.

Additional Diagnostic Tests

  • Imaging Studies
  • Clinical Evaluation
  • Brain MRI
  • Nerve Conduction Studies
  • Molecular Genetic Tests

Treatment

Current Status of Drug Treatment for VWM4

Leukoencephalopathy with vanishing white matter 4 (VWM4) is a chronic and progressive autosomal recessive leukoencephalopathy characterized by neurologic deterioration. While there is currently no cure for VWM, it is treatable. With proactive, comprehensive medical care, affected individuals can avoid unnecessary suffering.

Promising Therapies

Advances in understanding the pathophysiology of VWM have led to the identification of promising therapies. However, currently, VWM has no approved treatments. Researchers are exploring various options, but more studies are needed to determine their efficacy and safety.

Alpha2-Adrenergic Antihypertensive Drugs

Guanabenz is an old, FDA-approved α2-adrenergic antihypertensive drug that has shown promise in treating VWM. Sephin1 has also received FDA orphan drug designation for the treatment of VWM. Guanabenz has proven safety in adults and may be safe to use in children aged 12 years and older.

Other Treatment Options

For many people with white matter disease due to small strokes, improving cardiovascular health through a healthy diet can be an effective treatment option. However, this approach is not directly applicable to VWM4, which has a distinct underlying cause.

Conclusion

While there are no approved treatments for VWM4, researchers are actively exploring promising therapies. Guanabenz and Sephin1 show potential as α2-adrenergic antihypertensive drugs that may be effective in treating VWM. Further studies are needed to confirm their efficacy and safety.

References:

  • [3] Leukoencephalopathy with vanishing white matter-4 (VWM4) is a chronic and progressive autosomal recessive leukoencephalopathy characterized by neurologic ...
  • [5] Although there is currently no cure for VWM, it is treatable. With proactive, comprehensive medical care, affected individuals can avoid unnecessary suffering ...
  • [6] by MS van der Knaap · 2022 · Cited by 19 — Guanabenz is an old, Food and Drug Administration (FDA)-approved α2-adrenergic antihypertensive drug. Sephin1 has FDA orphan drug designation ...
  • [7] “Guanabenz is an alpha2-adrenergic antihypertensive drug with proven safety in adults. Evidence also supports safe use in children aged 12 years and older.
  • [9] Leukoencephalopathy with vanishing white matter (VWM disease) is an autosomal recessive neurological disease. The cause of the disease are mutations in any ...
  • [10] For many people with white matter disease due to small strokes, treatment options can include improving their cardiovascular health by eating a healthful diet, ...

Recommended Medications

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis for leukoencephalopathy with vanishing white matter (VWM) includes a spectrum of early onset leukodystrophies, such as Alexander's disease. This is primarily based on the MRI pattern.

  • Alexander's disease: A rare and severe leukodystrophy that affects the brain's white matter, leading to progressive neurological decline.
  • Other early onset leukodystrophies: Conditions like Canavan disease, Krabbe disease, and Pelizaeus-Merzbacher disease can also be considered in the differential diagnosis of VWM.

The key is to carefully evaluate the MRI findings and consider other potential causes based on the patient's clinical presentation.

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2243
owl#annotatedSource
t350033
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0070371
core#notation
DOID:0070371
oboInOwl#hasDbXref
MIM:620314
core#exactMatch
MIM:620314
IAO_0000115
A leukoencephalopathy with vanishing white matter that has_material_basis_in compound heterozygous mutation in the EIF2B4 gene on chromosome 2p23.
rdf-schema#label
leukoencephalopathy with vanishing white matter 4
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0060868
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.